Product Code: GVR-2-68038-683-7
Surgical Sutures Market Summary
The global surgical sutures market size was estimated at USD 5.02 billion in 2025 and is projected to reach USD 7.41 billion by 2033, growing at a CAGR of 4.98% from 2026 to 2033. The market is primarily driven by the rising volume of surgical procedures worldwide, fueled by the increasing prevalence of chronic diseases and an aging population requiring surgical interventions.
In addition, advancements in suture materials, such as antimicrobial and absorbable sutures, enhance patient outcomes and reduce infection risks, further boosting adoption. Growing healthcare infrastructure and access to surgical care in emerging economies also contribute significantly to market expansion.
The demand for wound closure products is rising owing to the growing number of surgical cases and the increasing prevalence of chronic wounds across the globe. According to the data published by Onenessbio in May 2025, approximately 6.3% of adults with diabetes worldwide suffer from diabetic foot ulcer (DFU). Such a burden of chronic wounds is anticipated to propel the demand for wound closure devices in the coming years. In addition, the rising incidence of road traffic accidents worldwide is expected to significantly drive the growth of the wound closure devices market.
Global Surgical Sutures Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2030. For this study, Grand View Research has segmented the global surgical sutures market report based on type, filament, application, and region:
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- Absorbable
- Non-absorbable
- Filament Outlook (Revenue, USD Million, 2021 - 2033)
- Monofilament
- Multifilament
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- General Surgery
- Ophthalmic Surgery
- Cardiovascular Surgery
- Orthopedic Surgery
- Neurological Surgery
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Thailand
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Type
- 1.1.2. Filament
- 1.1.3. Application
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.5. Details of primary research
- 1.5.1. Data for primary interviews in North America
- 1.5.2. Data for primary interviews in Europe
- 1.5.3. Data for primary interviews in Asia Pacific
- 1.5.4. Data for primary interviews in Latin America
- 1.5.5. Data for Primary interviews in MEA
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.1.1. Approach 1: Commodity flow approach
- 1.7.2. Volume price analysis (Model 2)
- 1.7.2.1. Approach 2: Volume price analysis
- 1.8. Research Scope and Assumptions
- 1.8.1. List of Secondary Sources
- 1.8.2. List of Primary Sources
- 1.8.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Surgical Sutures Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. Growing number of surgical procedures
- 3.2.1.2. Advancements in suture material and technology
- 3.2.1.3. Increasing partnerships for distribution
- 3.2.2. Market Restraints Analysis
- 3.2.3. Market Opportunity Analysis
- 3.2.3.1. Increasing number of clinical trials
- 3.2.3.2. Expanding opportunities in emerging economies
- 3.2.3.3. Rising launches of novel products
- 3.2.3.4. Regulatory and development opportunities for antibacterial and electrical sutures
- 3.2.4. Market Challenge Analysis
- 3.2.4.1. Availability of alternatives
- 3.3. Surgical Sutures Market Analysis Tools
- 3.3.1. Porter's Analysis
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal landscape
Chapter 4. Surgical Sutures Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Surgical Sutures Market: Type Movement Analysis, 2025 & 2033 (USD Million)
- 4.3. Global Surgical Sutures Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
- 4.3.1. Absorbable
- 4.3.1.1. Absorbable market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.2. Non-absorbable
- 4.3.2.1. Non-absorbable market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Surgical Sutures Market: Filament Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Surgical Sutures Market: Filament Movement Analysis, 2025 & 2033 (USD Million)
- 5.3. Global Surgical Sutures Market Size & Trend Analysis, by Filament, 2021 to 2033 (USD Million)
- 5.3.1. Monofilament
- 5.3.1.1. Monofilament market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 5.3.2. Multifilament
- 5.3.2.1. Multifilament market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Surgical Sutures Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Surgical Sutures Market: Application Movement Analysis, 2025 & 2033 (USD Million)
- 6.3. Global Surgical Sutures Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 6.3.1. General Surgery
- 6.3.1.1. General surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.2. Ophthalmic Surgery
- 6.3.2.1. Ophthalmic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.3. Cardiovascular Surgery
- 6.3.3.1. Cardiovascular surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.4. Orthopedic Surgery
- 6.3.4.1. Orthopedic surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.5. Neurological Surgery
- 6.3.5.1. Neurological surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.6. Others
- 6.3.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Surgical Sutures Market: Regional Estimates & Trend Analysis by Type, Filament, and Application
- 7.1. Regional Dashboard
- 7.2. Market Size and Trend Analysis, 2021 to 2033
- 7.3. North America
- 7.3.1. North America surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Competitive scenario
- 7.3.2.3. Regulatory framework
- 7.3.2.4. Reimbursement scenario
- 7.3.2.5. U.S. surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Competitive scenario
- 7.3.3.3. Regulatory framework
- 7.3.3.4. Reimbursement scenario
- 7.3.3.5. Canada surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Competitive scenario
- 7.3.4.3. Regulatory framework
- 7.3.4.4. Reimbursement scenario
- 7.3.4.5. Mexico surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Europe surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Competitive scenario
- 7.4.2.3. Regulatory framework
- 7.4.2.4. Reimbursement scenario
- 7.4.2.5. UK surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Competitive scenario
- 7.4.3.3. Regulatory framework
- 7.4.3.4. Reimbursement scenario
- 7.4.3.5. Germany surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Competitive scenario
- 7.4.4.3. Regulatory framework
- 7.4.4.4. Reimbursement scenario
- 7.4.4.5. France surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Competitive scenario
- 7.4.5.3. Regulatory framework
- 7.4.5.4. Reimbursement scenario
- 7.4.5.5. Italy surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Competitive scenario
- 7.4.6.3. Regulatory framework
- 7.4.6.4. Reimbursement scenario
- 7.4.6.5. Spain surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Competitive scenario
- 7.4.7.3. Regulatory framework
- 7.4.7.4. Reimbursement scenario
- 7.4.7.5. Sweden surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Competitive scenario
- 7.4.8.3. Regulatory framework
- 7.4.8.4. Reimbursement scenario
- 7.4.8.5. Denmark surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key country dynamics
- 7.4.9.2. Competitive scenario
- 7.4.9.3. Regulatory framework
- 7.4.9.4. Reimbursement scenario
- 7.4.9.5. Norway surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. China surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Japan
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. Japan surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Competitive scenario
- 7.5.4.3. Regulatory framework
- 7.5.4.4. Reimbursement scenario
- 7.5.4.5. India surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Competitive scenario
- 7.5.5.3. Regulatory framework
- 7.5.5.4. Reimbursement scenario
- 7.5.5.5. South Korea surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Competitive scenario
- 7.5.6.3. Regulatory framework
- 7.5.6.4. Reimbursement scenario
- 7.5.6.5. Australia surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Competitive scenario
- 7.5.7.3. Regulatory framework
- 7.5.7.4. Reimbursement scenario
- 7.5.7.5. Thailand surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. Brazil surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive scenario
- 7.6.3.3. Regulatory framework
- 7.6.3.4. Reimbursement scenario
- 7.6.3.5. Argentina surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7. Middle East and Africa
- 7.7.1. Middle East and Africa surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. South Africa surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. Saudi Arabia surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive scenario
- 7.7.4.3. Regulatory framework
- 7.7.4.4. Reimbursement scenario
- 7.7.4.5. UAE surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Competitive scenario
- 7.7.5.3. Regulatory framework
- 7.7.5.4. Reimbursement scenario
- 7.7.5.5. Kuwait surgical sutures market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Market Share Analysis, 2025
- 8.4. Company Heat Map Analysis
- 8.5. Strategy Mapping
- 8.5.1. Expansion
- 8.5.2. Mergers & Acquisition
- 8.5.3. Partnerships & Collaborations
- 8.5.4. New Product Launches
- 8.5.5. Research And Development
- 8.5.6. Company Profiles
- 8.5.7. B. Braun SE
- 8.5.7.1. Company overview
- 8.5.7.2. Financial performance
- 8.5.7.3. Product Benchmarking
- 8.5.7.4. Strategic initiatives
- 8.5.8. Stryker
- 8.5.8.1. Company overview
- 8.5.8.2. Financial performance
- 8.5.8.3. Product Benchmarking
- 8.5.8.4. Strategic initiatives
- 8.5.9. Smith+Nephew
- 8.5.9.1. Company overview
- 8.5.9.2. Financial performance
- 8.5.9.3. Product Benchmarking
- 8.5.9.4. Strategic initiatives
- 8.5.10. Medtronic
- 8.5.10.1. Company overview
- 8.5.10.2. Financial performance
- 8.5.10.3. Product Benchmarking
- 8.5.10.4. Strategic initiatives
- 8.5.11. Ethicon (Johnson & Johnson)
- 8.5.11.1. Company overview
- 8.5.11.2. Financial performance
- 8.5.11.3. Product Benchmarking
- 8.5.11.4. Strategic initiatives
- 8.5.12. Riverpoint Medical
- 8.5.12.1. Company overview
- 8.5.12.2. Financial performance
- 8.5.12.3. Product Benchmarking
- 8.5.12.4. Strategic initiatives
- 8.5.13. Dynarex Corporation
- 8.5.13.1. Company overview
- 8.5.13.2. Financial performance
- 8.5.13.3. Product Benchmarking
- 8.5.13.4. Strategic initiatives
- 8.5.14. Corza Medical
- 8.5.14.1. Company overview
- 8.5.14.2. Financial performance
- 8.5.14.3. Product Benchmarking
- 8.5.14.4. Strategic initiatives
- 8.5.15. Healthium Medtech Ltd.
- 8.5.15.1. Company overview
- 8.5.15.2. Financial performance
- 8.5.15.3. Product Benchmarking
- 8.5.15.4. Strategic initiatives
- 8.5.16. Advanced Medical Solutions Group plc
- 8.5.16.1. Company overview
- 8.5.16.2. Financial performance
- 8.5.16.3. Product Benchmarking
- 8.5.16.4. Strategic initiatives
- 8.5.17. Meril
- 8.5.17.1. Company overview
- 8.5.17.2. Financial performance
- 8.5.17.3. Product Benchmarking
- 8.5.17.4. Strategic initiatives
- 8.5.18. Lotus Surgicals Pvt Ltd (TI Medical, a Murugappa Group company)
- 8.5.18.1. Company overview
- 8.5.18.2. Financial performance
- 8.5.18.3. Product Benchmarking
- 8.5.18.4. Strategic initiatives
- 8.5.19. DemeTECH Corporation
- 8.5.19.1. Company overview
- 8.5.19.2. Financial performance
- 8.5.19.3. Product Benchmarking
- 8.5.19.4. Strategic initiatives